Paxlovid does not increase risk of COVID reinfection: study

Published Date: 16 Feb 2023

Although there are concerns that the use of Paxlovid increases the risk of COVID-19 returning, the results are clear.

Read Full News

Latest News

Is the Viral Plastic Diet Linked to Eating Disorder Risk?

A viral plastic diet trend raises concerns for choking, metabolic disruption, and increased risk for eating disorders among youth.

How the Gulf Crisis Is Reaching Europe’s Pharmacies

Conflict in the Gulf is exposing how dependent Europe’s pharmacies are on global supply chains for essential medicines, active ingredients, and transport.

Acute Severe Ulcerative Colitis: 10 Risks in Older Adults

Older adults with acute severe ulcerative colitis have higher mortality, underscoring the need for targeted strategies to reduce the risk for adverse events and enable timely treatment decisions.

The Flaws in the New HHS Nutrition Education Initiative

Doctors aren't dietitians. Fantuzzi and Straughan unpack the flaws in the new HHS nutrition competencies and advocate for collaborative care.

Antidepressant Promising for Methamphetamine Addiction

There are no approved medications for methamphetamine use disorder, but phase 3 trial results suggest the generic antidepressant mirtazapine may offer modest but significant reductions in use.

Proximity to Nuclear Plants Linked to Cancer Mortality

A US ecologic study finds higher cancer mortality in counties closer to nuclear plants, but results reflect association and require cautious clinical interpretation.

Todays Updates

Low Income, Education Tied to Depression in Older Adults

Older adults with chronic disease who have less education, lower income, and no active jobs tend to experience symptoms of depression.

Infection Burden High With Myeloma T-Cell Therapies

A retrospective study suggests a high burden of prolonged, mostly low-grade infections in patients with multiple myeloma who receive T-cell-engaging therapies.

Weight-Based and Fixed-Dose Pembrolizumab Compared in NSCLC

A national cohort study compares the safety and efficacy of weight-based and fixed-dose pembrolizumab regimens in patients with advanced non-small cell lung cancer.

HER2 ADC Shows Promise in Recurrent Endometrial Cancer

Trastuzumab pamirtecan, a HER2-targeted antibody-drug conjugate, achieved ‘exceptional’ antitumor responses in patients with recurrent endometrial cancer, especially those with HER2 IHC 3+ tumors.

Todays Updates

Low Income, Education Tied to Depression in Older Adults

Older adults with chronic disease who have less education, lower income, and no active jobs tend to experience symptoms of depression.

Infection Burden High With Myeloma T-Cell Therapies

A retrospective study suggests a high burden of prolonged, mostly low-grade infections in patients with multiple myeloma who receive T-cell-engaging therapies.

Weight-Based and Fixed-Dose Pembrolizumab Compared in NSCLC

A national cohort study compares the safety and efficacy of weight-based and fixed-dose pembrolizumab regimens in patients with advanced non-small cell lung cancer.

HER2 ADC Shows Promise in Recurrent Endometrial Cancer

Trastuzumab pamirtecan, a HER2-targeted antibody-drug conjugate, achieved ‘exceptional’ antitumor responses in patients with recurrent endometrial cancer, especially those with HER2 IHC 3+ tumors.

Latest News

A viral plastic diet trend raises concerns for choking, metabolic disruption, and increased risk for eating disorders among youth.

Conflict in the Gulf is exposing how dependent Europe’s pharmacies are on global supply chains for essential medicines, active ingredients, and transport.

Older adults with acute severe ulcerative colitis have higher mortality, underscoring the need for targeted strategies to reduce the risk for adverse events and enable timely treatment decisions.

Doctors aren't dietitians. Fantuzzi and Straughan unpack the flaws in the new HHS nutrition competencies and advocate for collaborative care.

There are no approved medications for methamphetamine use disorder, but phase 3 trial results suggest the generic antidepressant mirtazapine may offer modest but significant reductions in use.

A US ecologic study finds higher cancer mortality in counties closer to nuclear plants, but results reflect association and require cautious clinical interpretation.

News All Time

Mystery Solved? How Psychedelics Affect the Brain

The largest analysis of psychedelic brain imaging to date offers a clearer picture of how psychedelic drugs affect the brain.

Ontario Researchers to Develop Advanced Imaging Platform

Western University researchers have been awarded $10.4 million for work intended to improve disease detection.

AI Scientist in Publishing: Is Peer Review Being Outpaced?

An AI system completes the full research cycle and passes peer review, but experts warn that limited oversight and unclear standards raise the risk for compromised scientific quality.

Preterm Birth, Low Birth Weight Tied to Learning Challenges

Individuals born preterm or with low birth weight had a lower IQ and struggled more with subjects such as reading and math in school.

Functional Seizures Linked to Higher Risk for Mortality

The risk for mortality is around twofold higher in patients with functional seizures than in those without seizure disorders but remains substantially lower than that in those with epileptic seizures.

CRC Prevention: Sessile Serrated Lesion Detection Is Key

A large study of adult colonoscopies found sessile serrated lesion detection rate was significantly associated with lower risk for postcolonoscopy colorectal cancer.

HIV No Longer Absolute Barrier to Breastfeeding

The shift reframes infant feeding as a discussion of risk rather than prohibition.

The Controversy Over Proton Therapy for Prostate Cancer

Does the evidence line up with the buzz surrounding the use of proton therapy to treat prostate cancer?

Regulator Acts on Racial Inequalities in Maternity Care

Regulator sets out new training approach as UK data show persistent disparities in maternal outcomes among ethnic minority women.

Early Relapse Signals High-Risk Primary Refractory LBCL

A secondary analysis of a phase 3 trial suggests that patients with relapse within 3 months of treatment or persistent disease represent a distinct high-risk group.

Kids With Developmental Disabilities Often Face Chronic Pain

Children with developmental disabilities are more likely to have parent-reported chronic pain than those without such conditions.

AI-Based Liver Screening Is Cost-Effective for Fibrosis

AI-based screening with transient elastography is more cost-effective than standard diagnostic approaches in identifying adults at risk for MASLD with advanced fibrosis.

Meningitis Deaths Top 250,000 a Year, Despite Global Decline

Meningitis incidence and mortality rates have declined globally since 1990, but progress toward meeting the 2030 WHO reduction targets is lagging, new research shows.

Pediatric Eating Difficulties Linked to Early Caries

Children with feeding issues often prefer sugary foods, increasing the risk for caries and long-term damage to primary and permanent teeth.

Personality Disorder May Delay Treatment in OCD

Obsessive-compulsive personality disorder is common in obsessive-compulsive disorder (OCD) and is linked to a significant delay in the initiation of OCD treatment, study shows.

Why Sulfur Burps Shouldn’t Be Ignored for GLP-1 Patients

Often unpleasant and unpredictable, these malodorous expressions could mask other side effects.

Recommended News For You

In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".

New BiTE Agent for Small Cell Lung Cancer Approved by the FDA.

The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.

According to a study, breast cancer in Syrian refugees tends to be diagnosed at an earlier stage and with more advanced tumors.

What Comes After Cancer?

EBV Screening Tied to Lower Nasopharyngeal Cancer Mortality Risk

Colon cancer and exercise: Can physical activity reprogram genes?

Recommended Articles For You

Does Lactate Signal Anemia? Exploring the Complexities of Hyperlactatemia and Red Blood Cell Health 

Recent Advances in Paroxysmal Nocturnal Hemoglobinuria Research: Promising Therapies on the Horizon  

Unlocking the Secrets of Improved Ovarian Cancer Survival Rates 

The Unseen Threat: Uncovering the Risks of Pancoast Tumor 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Recurrent UTIs impact eGFR in children with vesicoureteral reflux

2.

Inner Thoughts of Leonard Bernstein, the "Maestro".

3.

The need for more Latinx participants in Alzheimer's trials is urgent.

4.

Potentially Novel Approach for Treating Advanced Colorectal Cancer with KRAS Mutations.

5.

BlurryScope: A compact, AI-powered microscope for rapid, cost-effective cancer scoring

1.

Evolving Cancer Treatments: Innovations, Success Rates, and Mechanisms

2.

Mechanistic Depth and Clinical Impact of Rusfertide, Onyvide, IV Avastin, and Pemfexy

3.

Refractory Iron Deficiency Anemia in a Young Adult: Diagnostic Challenges

4.

The Complications and Treatments of Intraosseous Hemangioma - A Comprehensive Guide

5.

Understanding Evans Syndrome: Causes, Symptoms, and Treatment Options 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII

4.

Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity

5.

Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot